Edition:
United States

Insider Trading: Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

0.42USD
27 May 2016
Change (% chg)

$0.01 (+1.68%)
Prev Close
$0.41
Open
$0.43
Day's High
$0.43
Day's Low
$0.39
Volume
219,584
Avg. Vol
374,791
52-wk High
$5.19
52-wk Low
$0.35

DP VII ASSOCIATES L P

Institutional Holders

% Shares Owned: 76.48%
# of Holders: 143
Total Shares Held: 111,327,363
3 Mo. Net Change: 7,281,718
# New Positions: 9
# Closed Positions: 27
# Increased Positions: 46
# Reduced Positions: 70
# Net Buyers: -24

Officers & Directors

Name Age Since Current Position

Eckard Weber

65 2009 Independent Chairman of the Board

Michael Narachi

55 2015 President, Chief Executive Officer, Interim Chief Financial Officer, Director

Thomas Lynch

2015 Executive Vice President, General Counsel, Secretary

Thomas Cannell

53 2015 Executive Vice President, Chief Commercial Officer

Preston Klassen

46

Peter Flynn

2016 Senior Vice President, Head - Development, Regulatory Affairs and Safety

Toni Foster

2016 Senior Vice President - Project Management Office and Clinical Operations

Chris Hazuka

2015 Acting General Counsel

Louis Bock

50 2005 Independent Director

Brian Dovey

74 2004 Independent Director

David Endicott

50 2012 Independent Director

Peter Honig

58 2010 Independent Director

Debora Jorn

2016 Independent Director

Patrick Mahaffy

53 2009 Independent Director

Lota Zoth

55 2012 Independent Director